Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) price on Friday, June 13, fall -13.03% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.34.
A look at the stock’s price movement, the close in the last trading session was $7.29. The PE ratio in trailing twelve months stood at 106.55. Turning to its 52-week performance, $14.30 and $3.50 were the 52-week high and 52-week low respectively. Overall, ZYBT moved -24.88% over the past month.
Zhengye Biotechnology Holding Ltd’s market cap currently stands at around $300.45 million, with investors looking forward to this quarter’s earnings report slated for in July.
ZYBT’s current price about -17.25% and -22.19% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 44.36, while 7-day volatility ratio is 14.06% and 11.91% in the 30-day chart. Further, Zhengye Biotechnology Holding Ltd (ZYBT) has a beta value of 0, and an average true range (ATR) of 1.82.
If we refocus on Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT), historical trading data shows that trading volumes averaged 581.47K over the past 3 months. The company’s latest data on shares outstanding shows there are 47.17 million shares.
The 90.66% of Zhengye Biotechnology Holding Ltd’s shares are in the hands of company insiders while institutional holders own 0.00% of the company’s shares. Current price change has pushed the stock 30.45% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ZYBT stock continues to rise going into the next quarter.
